Loyal
Extending the lifespan of dogs
About Loyal
Loyal is a clinical-stage veterinary medicine company developing drugs intended to extend the lifespan and healthspan of dogs. In other words, our mission is to help dogs live longer, healthier lives.
Pitch deck breakdown
How Loyal would pitch themselves.
Target customer
Business teams looking for modern saas tooling — replacing legacy software or building net-new workflows in this category.
Problem they solve
Loyal is a clinical-stage veterinary medicine company developing drugs intended to extend the lifespan and healthspan of dogs. In other words, our mission is to help dogs live longer, healthier lives. The category has historically been served by tools that miss the modern workflow this product is built around.
Key differentiator
Loyal differentiates on extending the lifespan of dogs. $0 raised — the company has resources + validation to compound this thesis.
Go-to-market strategy
Growth-stage GTM — multi-channel revenue motion (direct enterprise sales, channel partnerships, marketplace listings). Vertical specialisation + verticalised AE teams targeting enterprise + mid-market.
Loyal website preview
Company facts
- Category
- SaaS
- Funding stage
- Series C
- Total raised
- $0
- Founded
- 2020
- Team size
- 51–200
- HQ
- San Francisco, United States
- Country
- United States
- Website
- loyal.com
Frequently asked questions
What does Loyal do?
Loyal is a clinical-stage veterinary medicine company developing drugs intended to extend the lifespan and healthspan of dogs. In other words, our mission is to help dogs live longer, healthier lives.
Where is Loyal based?
Loyal is based in San Francisco, United States, United States.
When was Loyal founded?
Loyal was founded in 2020.
How much has Loyal raised?
Loyal has raised $0 in their Series C round.